EM Imaging radiopharmaceuticals portfolio

Edinburgh Molecular Imaging has a portfolio of agents designed to improve detection and treatment of Cancer. All Agents progressed to date have been found to be safe, specific, sensitive and selective.

PET Imaging


Indications to be disclosed at a later stage.

About Us

EM Imaging was founded in 2014 to develop a versatile and disease focused approach to optical tracer and therapeutic compounds development.

Edinburgh Molecular Imaging Ltd.

9 Little France Road
Edinburgh BioQuarter (Gate 3)
Edinburgh EH16 4UX
United Kingdom

Edinburgh Molecular Imaging – 2021